Bill Text: NY A06627 | 2023-2024 | General Assembly | Amended

NOTE: There are more recent revisions of this legislation. Read Latest Draft

---

Bill Title: Allows a licensed pharmacist to order and administer certain tests.

Spectrum: Moderate Partisan Bill (Democrat 21-6)

Status: (Introduced) 2024-01-05 - print number 6627b [A06627 Detail]

Download: New_York-2023-A06627-Amended.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                         6627--A

                               2023-2024 Regular Sessions

                   IN ASSEMBLY

                                     April 24, 2023
                                       ___________

        Introduced  by  M.  of  A.  McDONALD, SAYEGH, WALLACE, SEAWRIGHT, MEEKS,
          JONES, JENSEN, LUPARDO, STIRPE, BUTTENSCHON, LUNSFORD  --  Multi-Spon-
          sored by -- M. of A.  TAGUE -- read once and referred to the Committee
          on  Higher  Education  --  committee discharged, bill amended, ordered
          reprinted as amended and recommitted to said committee

        AN ACT to amend the education law, in relation to  allowing  a  licensed
          pharmacist  to  order and administer respiratory syncytial virus (RSV)
          and Group A streptococcal tests and to initiate treatment  upon  posi-
          tive results of COVID-19, influenza and Group A streptococcal tests

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subdivision 7 of section 6801  of  the  education  law,  as
     2  added  by  section  2  of  part  C of chapter 57 of the laws of 2022, is
     3  amended to read as follows:
     4    7. A licensed pharmacist is a qualified health care professional under
     5  section five hundred seventy-one  of  the  public  health  law  for  the
     6  purposes  of  directing  a  limited  service laboratory and ordering and
     7  administering COVID-19 [and],  influenza,  respiratory  syncytial  virus
     8  (RSV),  Group A streptococcal, HbA1c, hepatitis C, and human immunodefi-
     9  ciency virus (HIV) tests authorized by the Food and Drug  Administration
    10  (FDA),  subject to certificate of waiver requirements established pursu-
    11  ant to the federal  clinical  laboratory  improvement  act  of  nineteen
    12  hundred eighty-eight.  A licensed pharmacist may also initiate treatment
    13  upon  positive  results of COVID-19, influenza and Group A streptococcal
    14  tests pursuant to a statewide protocol approved  by  the  department  of
    15  health.    A  pharmacist  shall  retain  a record of the test result and
    16  treatment as part of the patient record and will provide,  upon  patient
    17  request,  a  report of the test result and treatment to patient's desig-
    18  nated physician, physician's assistant or nurse practitioner.
    19    § 2. This act shall take effect immediately; provided,  however,  that
    20  the  amendments  to  subdivision  7 of section 6801 of the education law
    21  made by section one of this act shall not  affect  the  repeal  of  such
    22  subdivision and shall be deemed repealed therewith.

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02558-02-3